XSHG
600249
Market cap438mUSD
Oct 09, Last price
5.44CNY
1D
1.87%
1Q
15.25%
Jan 2017
-40.55%
IPO
61.98%
Name
Liuzhou Liangmianzhen Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1941 and headquartered in Liuzhou, China, Liuzhou Liangmianzhen Co., Ltd. functions as a broad-ranging manufacturer and distributor with a global presence, serving markets in China, Hong Kong, Macau, North America, Western Europe, South Asia, and Africa. The company's extensive product portfolio prominently features oral hygiene solutions, including its LMZ Herbal and Fangcao brand toothpastes, as well as toothbrushes and mouthwashes. Beyond dental care, it also supplies a variety of personal care items like body and facial products, alongside essential hygiene articles such as sanitary towels and paper goods. Furthermore, its operations extend to producing sucralose sweeteners for the food industry and pharmaceutical goods, including bulk drugs, tablets, capsules, and granules. The company also offers household cleaning agents, specifically for laundry, pesticide residue degradation, and dishwashing. Rounding out its diverse offerings are travel kits and engagement in real estate development.
Key people
Yunxiang Zhou
Chairman of the Board · since 2025
Huiquan Gong
President, Vice Chairman of the Board, Acting Finance Director · since 2026
Weimin Wang
Chief Financial Officer, Vice President, Director · since 2017
Jianfeng Xiong
Vice President, Director · since 2026
Ling Yang
Vice President · since 2019
Yuanxian Wei
Secretary of the Board · since 2026
Gui Liu
Director · since 2026
Jianfeng Sun
Director · since 2026
Juan Yu
Staff Elected Director · since 2026
Zhongliang Guan
Independent Director · since 2026
Tingting Liu
Independent Director · since 2026
Xiu Yang
Independent Director · since 2026
Headquarters & legal address
区柳州市柳州市东环大道282号
南宁市, GX 100000
CN
南宁市, GX 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2018‑00 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||